Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002388632 | SCV002668644 | uncertain significance | Cardiovascular phenotype | 2022-09-30 | criteria provided, single submitter | clinical testing | The p.R253C variant (also known as c.757C>T), located in coding exon 7 of the CASQ2 gene, results from a C to T substitution at nucleotide position 757. The arginine at codon 253 is replaced by cysteine, an amino acid with highly dissimilar properties. This variant was detected in an arrhythmia genetic testing cohort; however, clinical details were limited, and additional cardiac variants were detected in some cases (van Lint FHM et al. Neth Heart J, 2019 Jun;27:304-309). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Clinical Genetics, |
RCV001699946 | SCV001925625 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001699946 | SCV001928011 | uncertain significance | not provided | no assertion criteria provided | clinical testing |